The American Journal of Medicine
Volume 122, Issue 2 , Pages 162.e1-162.e9 , February 2009

“Dose-dependent” Impact of Recurrent Cardiac Events on Mortality in Patients with Heart Failure

  • Douglas S. Lee, MD, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • Division of Cardiology of University Health Network and Mt. Sinai Hospital, Toronto, Ont, Canada
    • Corresponding Author InformationRequests for reprints should be addressed to Douglas S. Lee, MD, PhD, Institute for Clinical Evaluative Sciences, Rm G-106, 2075 Bayview Ave., Toronto, ON, Canada
    • ,
  • Peter C. Austin, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • Department of Health Policy, Management and Evaluation, Toronto, Ont, Canada
    • ,
  • Thérèse A. Stukel, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • Department of Health Policy, Management and Evaluation, Toronto, Ont, Canada
    • ,
  • David A. Alter, MD, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • Department of Health Policy, Management and Evaluation, Toronto, Ont, Canada
    • Division of Cardiology of St. Michael's Hospital, Toronto, Ont, Canada
    • ,
  • Alice Chong, BSc

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • ,
  • John D. Parker, MD

      Affiliations

    • Division of Cardiology of University Health Network and Mt. Sinai Hospital, Toronto, Ont, Canada
    • ,
  • Jack V. Tu, MD, PhD

      Affiliations

    • Institute for Clinical Evaluative Sciences, Toronto, Ont, Canada
    • Department of Health Policy, Management and Evaluation, Toronto, Ont, Canada
    • Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ont, Canada

References 

  1. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med. 2007;167:490–496
  2. Krumholz HM, Chen YT, Wang Y, et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139:72–77
  3. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226–1233
  4. Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol. 1997;79:1640–1644
  5. Rame JE, Sheffield MA, Dries DL, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 2001;142:714–719
  6. Tsuyuki RT, McKelvie RS, Arnold JM, et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161:2337–2342
  7. Solomon SD, Dobson J, Pocock S, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482–1487
  8. Ahmed A, Allman RM, Fonarow GC, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail. 2008;14:211–218
  9. Lee DS, Pencina MJ, Benjamin EJ, et al. Association of parental heart failure with risk of heart failure in offspring. N Engl J Med. 2006;355:138–147
  10. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581–2587
  11. Lee DS, Tu JV, Juurlink DN, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247
  12. Tu JV, Bowen J, Chiu M, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007;357:1393–1402
  13. Lee DS, Donovan L, Austin PC, et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005;43:182–188
  14. International Classification of Diseases. Clinical Modification. 9th Revision. Washington, DC: Public Health Service, US Department of Health and Human Services; 1988;
  15. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva, Switzerland: World Health Organization; 1992;
  16. Rosner B. Fundamentals of Biostatistics. Belmont, CA: Duxbury; 2000;
  17. Kellett J. Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations>100 pg/ml: comparison of a clinical model with brain natriuretic peptide concentrations. Heart. 2006;92:1512–1513
  18. Ko DT, Tu JV, Masoudi FA, et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med. 2005;165:2486–2492
  19. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
  20. Rector TS, Ringwala SN, Ringwala SN, Anand IS. Validation of a risk score for dying within 1 year of an admission for heart failure. J Card Fail. 2006;12:276–280
  21. Ko DT, Alter DA, Austin PC, et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J. 2008;155:324–331
  22. Hosmer DW, Lemeshow S. Applied Survival Analysis. New York: John Wiley and Sons, Inc; 1999;
  23. Teuteberg JJ, Lewis EF, Nohria A, et al. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail. 2006;12:47–53
  24. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65–75
  25. Pearte CA, Furberg CD, O'Meara ES, et al. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation. 2006;113:2177–2185
  26. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260–266
  27. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: collaborative group on ACE inhibitor trials. JAMA. 1995;273:1450–1456
  28. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF) (MERIT-HF Study Group). JAMA. 2000;283:1295–1302

 Funding: This research was supported by a Canadian Institutes of Health Research (CIHR) grant and a CIHR Team Grant in Cardiovascular Outcomes Research, a clinician-scientist (DSL) and new investigator award (PCA) from the CIHR, career investigator awards from the Heart and Stroke Foundation of Ontario (JVT, DAA), and a Canada Research Chair in health services research (JVT).

 Conflict of Interest: The authors have no conflict of interest to disclose.

 Authorship: All co-authors had access to the data and contributed to the manuscript.

PII: S0002-9343(08)00958-3

doi: 10.1016/j.amjmed.2008.08.026

The American Journal of Medicine
Volume 122, Issue 2 , Pages 162.e1-162.e9 , February 2009

Article Tools

* Image Usage & Resolution